By Senior Editor Danielle Kirsh and Associate Editor Sean Whooley From pulsed field ablation to diabetes, surgical robotics, and much more, we see a number of significant medical device launches on the horizon in 2024. Pulsed field ablation news took over at the end of 2023 and the start of 2024, with Medtronic and Boston […]
Medtronic
Medtronic unveils new AI for laparoscopic, robotic surgery tech
Medtronic today announced new AI capabilities to go with the launch of its Touch Surgery Live Stream digital offering. The medtech giant’s 14 new AI algorithms enhance its digital capabilities within post-operative analysis. Medtronic said they provide AI surgical insights across laparoscopic and robotic-assisted surgery. Along with the algorithms, Medtronic launched its Touch Surgery Live […]
Medtronic survey reveals barriers to women’s heart health care
A Medtronic survey recently revealed a lack of awareness among women regarding heart valve disease and the risk factors. The survey examined women’s perceptions and knowledge of risk factors, treatment patterns, and preventative care practices related to heart valve disease. It was endorsed by Women as One and conducted by Wakefield Research, which sampled 1,000 […]
Medtronic unveils next-gen GI Genius software, partners with ModMed on AI-powered colonoscopy
Medtronic today announced advancements for its AI-powered GI Genius system, as well as a new collaboration. The company unveiled its ColonPRO latest-generation software for the GI Genius intelligent endoscopy system. GI Genius, a computer-aided polyp detection system powered by AI, has been available in the U.S. since 2021. Medtronic designed it to redefine GI screening by […]
OM1, Medtronic partner on drug-eluting implant study
OM1 today announced positive results from its partnership with Medtronic (NYSE:MDT) evaluating the Propel corticosteroid-eluting implants. The Propel bioabsorbable implant family came to Medtronic through its acquisition of IntersectENT in 2022. OM1 and Medtronic partnered on their study to focus on healthcare resource use and long-term outcomes in patients with chronic rhinosinusitis (CRS) who underwent […]
Medtronic has positive data for single-shot mapping ablation catheter
Medtronic today announced positive clinical trial data for its Sphere-360 investigational pulsed field ablation (PFA) catheter technology. The single-shot mapping and ablation catheter uses pulsed field energy to treat patients with paroxysmal AFib. Medtronic presented interim findings on the system at the European Heart Rhythm Association (EHRA) 2024 Annual Meeting. Designed with the goal to […]
Medtronic says Evolut TAVR outperformed Edwards Sapien in head-to-head trial
Medtronic today announced data from a head-to-head trial backing its Evolut TAVR system against the Edwards Sapien platform. The medtech giant presented results from the one-year SMART trial at the American College of Cardiology Annual Scientific Session. It simultaneously published the study results in The New England Journal of Medicine. SMART evaluated Evolut and Sapien […]
President of Medtronic Gastrointestinal is leaving, replacement named
Gio Di Napoli, president of the Gastrointestinal business at Medtronic , announced today that he is departing his post at the medtech giant. His leaving marks the second departure of a business unit president at Medtronic this month. Ariel Mactavish, president of the company’s Respiratory Interventions unit, also announced that she was leaving the company. […]
Tandem Diabetes Care taps miniaturization and automation for its latest systems
Tandem Diabetes Care (Nasdaq:TNDM) EVP and Chief Strategy Officer Elizabeth Gasser didn’t exactly plan for the whirlwind past year or so. In the space of about two months, Tandem announced continuous glucose monitor (CGM) integration with the latest-generation technology from Dexcom and Abbott, launched its Tandem Source diabetes management platform and began the rollout of […]
FDA approves next-gen Evolut TAVR system from Medtronic
Medtronic announced today that the FDA approved its next-generation Evolut FX+ transcatheter aortic valve replacement (TAVR) system. The FDA’s approval covers the treatment of symptomatic aortic stenosis. Medtronic says the latest version of the Evolut valve maintains the performance of the Evolut platform with a design that facilitates coronary access. Evolut FX+ TAVR offers larger […]
PTAB upholds two Medtronic patents in spat with Axonics, could go to jury trial
Medtronic announced today that the U.S. Patent and Trademark Office upheld many of its claims around two of its patents in its battle with Axonics (Nasdaq:AXNX). The office’s Patent Trial and Appeal Board (PTAB) affirmed the validity of many of the claims in two of Medtronic’s patents in the latest development in a long-running spat […]